Skip to main content
SINSIN PHARMACEUTICAL Co., LTD. logo

SINSIN PHARMACEUTICAL Co., LTD. — Investor Relations & Filings

Ticker · 002800 ISIN · KR7002800001 KO Manufacturing
Open in API
Filings indexed 175 across all filing types
Latest filing 2025-10-29 Major Shareholding Noti…
Country KR South Korea
Listing KO 002800

About SINSIN PHARMACEUTICAL Co., LTD.

https://sinsin2002.tradekorea.com/

Sinsin Pharmaceutical Co., Ltd. is a pharmaceutical company that specializes in the development, manufacturing, and marketing of over-the-counter (OTC) medicines for external use. The company's core product portfolio centers on topical anti-inflammatory and analgesic drugs, including its widely recognized brand of pain relief patches, "SINSIN PAS," alongside various sprays and lotions. The company also produces a diverse range of consumer healthcare items such as mosquito repellents, wound care products like surgical plasters and healing bands, anti-mycotic treatments, and other dermatological preparations for both domestic and overseas markets.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Major Shareholding Notification Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' which translates to 'Report on Ownership Status of Specific Securities by Executives and Major Shareholders.' It includes detailed information about securities ownership, changes in holdings, and related personal and company data. The document is addressed to regulatory bodies such as the Securities and Futures Commission and the Korea Exchange, indicating it is a formal disclosure of insider holdings. This matches the definition of a Major Shareholding Notification, which involves reporting changes in significant share ownership levels. The document length is 2415 characters, which is consistent with a detailed notification rather than a full financial report or announcement. Therefore, the appropriate classification is Major Shareholding Notification (MRQ).
2025-10-29 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' which translates to 'Report on Ownership Status of Specific Securities by Executives and Major Shareholders.' It includes detailed information about securities ownership, changes in holdings, and related dates. The document references regulatory bodies such as the Securities and Futures Commission and the Korea Exchange, indicating it is a regulatory filing related to insider or major shareholder holdings. The content is a report of personal share transactions or holdings by company directors or executives, which matches the definition of 'Director's Dealing' filings. The document length is 2462 characters, which is consistent with a detailed insider transaction report rather than a brief announcement or a full financial report. Therefore, the appropriate classification is 'DIRS' (Director's Dealing).
2025-10-02 Korean
반기보고서 (2025.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-Annual Report) for Sinsin Pharmaceutical Co., Ltd., covering the period from January 1, 2025, to June 30, 2025. It contains detailed financial data, business operations, management discussions, and capital structure information. As it is a comprehensive financial report for a period shorter than a full fiscal year, it falls under the 'Interim / Quarterly Report' category. H1 2025
2025-08-14 Korean
분기보고서 (2025.03)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for Sinsin Pharmaceutical Co., Ltd. for the period ending March 31, 2025. It contains detailed financial information, business operations, management discussion, and financial statements, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2025
2025-05-14 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official announcement of the results of a General Meeting of Shareholders (정기주주총회결과). It details the outcomes of voting on agenda items such as financial statement approval, dividend declarations, director appointments, and amendments to business purposes. This falls under the category of Declaration of Voting Results & Voting Rights Announcements.
2025-03-26 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 100% confidence The document is a formal regulatory filing submitted to the Financial Services Commission/Korea Exchange regarding the appointment, dismissal, or resignation of an outside director (사외이사). This type of corporate governance disclosure specifically pertains to changes in the board of directors, which falls under the 'Board/Management Information' category.
2025-03-26 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.